Trial Profile
A phase I study of a sphingosine 1 receptor agonist.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 19 Jan 2012
Price :
$35
*
At a glance
- Drugs Cenerimod (Primary)
- Indications Systemic lupus erythematosus
- Focus Adverse reactions
- 19 Jan 2012 New trial record